| # | Drug | Count |
|---|---|---|
| 0 | ETANERCEPT | 44 |
| 1 | ADALIMUMAB | 38 |
| 2 | METHOTREXATE SODIUM | 35 |
| 3 | METHOTREXATE | 33 |
| 4 | PREDNISONE | 26 |
| 5 | OMEPRAZOLE MAGNESIUM | 24 |
| 6 | PREGABALIN | 20 |
| 7 | CELECOXIB | 19 |
| 8 | ALENDRONATE SODIUM | 18 |
| 9 | METFORMIN | 18 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | BRYONIA (ALBA), CARDUUS MARIANUS, CHELIDONIUM MAJUS, HEPAR SUIS, TARAXACUM OFFICINALE | 1 | 0.0769 |
| 1 | DEXBROMPHENIRAMINE MALEATE, DEXTROMETHORPHAN HYDROBROMIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE | 1 | 0.0123 |
| 2 | HYDROCORTISONE ACETATE AND PRAMOXINE HYDROCHLORIDE | 1 | 0.0047 |
| 3 | BACTERIOSTATIC WATER | 1 | 0.0024 |
| 4 | ELOSULFASE ALFA | 9 | 0.0016 |
| 5 | CARMUSTINE | 7 | 0.0015 |
| 6 | PHENOBARBITAL, HYOSCYAMINE SULFATE, ATROPINE SULFATE, SCOPOLAMINE HYDROBROMIDE | 1 | 0.0011 |
| 7 | CHLOROTHIAZIDE SODIUM | 1 | 0.0011 |
| 8 | SODIUM FLUORIDE AND POTASSIUM NITRATE | 1 | 0.0010 |
| 9 | AVUTOMETINIB POTASSIUM AND DEFACTINIB HYDROCHLORIDE | 1 | 0.0009 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nonsteroidal Anti-inflammatory Drug [EPC] | 59 |
| 1 | Corticosteroid [EPC] | 54 |
| 2 | Tumor Necrosis Factor Blocker [EPC] | 53 |
| 3 | Folate Analog Metabolic Inhibitor [EPC] | 33 |
| 4 | Proton Pump Inhibitor [EPC] | 30 |
| 5 | Benzodiazepine [EPC] | 23 |
| 6 | Angiotensin 2 Receptor Blocker [EPC] | 17 |
| 7 | Provitamin D2 Compound [EPC] | 17 |
| 8 | Vitamin C [EPC] | 17 |
| 9 | Interleukin-17A Antagonist [EPC] | 16 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC] | 13 | 0.0010 |
| 1 | Calcitonin [EPC] | 2 | 0.0006 |
| 2 | Tissue-nonspecific Alkaline Phosphatase [EPC] | 6 | 0.0006 |
| 3 | Provitamin D2 Compound [EPC] | 17 | 0.0006 |
| 4 | Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC] | 4 | 0.0005 |
| 5 | Bismuth [EPC] | 3 | 0.0005 |
| 6 | Survival of Motor Neuron 2 Splicing Modifier [EPC] | 2 | 0.0005 |
| 7 | Interleukin-17A Antagonist [EPC] | 16 | 0.0004 |
| 8 | Glucosylceramide Synthase Inhibitor [EPC] | 1 | 0.0004 |
| 9 | Antisense Oligonucleotide [EPC] | 4 | 0.0003 |